.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

CME Opportunities

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Drs Leonard Gomella and Daniel Petrylak

EP. 1: When to Image: Earlier?

March 19th 2015

EP. 2: Looking Forward: Immunotherapy and Genomics

March 19th 2015

EP. 3: MAINSAIL: Lessons Learned

March 19th 2015

EP. 4: Abiraterone: Approval and Use

March 19th 2015

EP. 5: Sequencing: Important Question With Many Answers

March 19th 2015

EP. 6: A Review of Bone-Targeted Therapies

March 19th 2015

EP. 7: Changes in NCCN Guideline: Affecting Second-Line

March 19th 2015

EP. 8: Sipuleucel-T: Evidence-based Use

March 19th 2015

EP. 9: Considerations in Treatment Selection

March 19th 2015

EP. 10: Changes in NCCN Guideline: Affecting First-Line

March 19th 2015

EP. 11: Prostate Cancer: Which Guidelines

March 19th 2015